Business Times of Missouri: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Times of Missouri.

Press releases published on August 24, 2026

Approbation du changement de dénomination sociale et du regroupement d’actions
Moderna and Merck Cancer Vaccine Success Is Good News for CancerVax
ServisFirst Bancshares, Inc. Ranks Sixth Among Top-Performing Banks with between $10 Billion to $50 Billion in Assets
A January deadline is a negotiating clock, strategist says
A Decade of Scientific Collaboration: DNA My Dog and Lakehead University’s Paleo-DNA Laboratory Celebrate Longstanding Partnership
UWMC INVESTOR ALERT: UWM Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead the UWM Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Shareholders who lost money in shares of Microvast Holdings, Inc. (NASDAQ: MVST) Should Contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of GPGI, Inc. (NYSE: GPGI) Should Contact Wolf Haldenstein Immediately
Halper Sadeh LLC is Investigating Whether WEAV, FULC, IRDM, TECH are Obtaining Fair Deals for their Shareholders
Inter-Rock Announces Normal Course Issuer Bid for Common Shares
Defiance Drone & Modern Warfare ETF (JEDI), The First ETF Providing Exposure to Shield AI, Surpasses $200 Million in AUM
Southwestern Ontario Home Hardware Group Launches SW Buy Local 50
Shareholders who lost money in shares of Smartsheet Inc. (NYSE: SMAR) should contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately
Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, CBZ are Obtaining Fair Deals for their Shareholders
Tyson Foods, Inc. Announces Pricing Terms of Previously Announced Debt Tender Offers
FS Bancorp, Inc. Authorizes Share Repurchase Program
RGNX Investor Notice: Johnson Fistel Investigates REGENXBIO Inc. Following Clinical Hold
UTZ BUYOUT ALERT: Kaskela Law Firm Announces Investigation into Price Adequacy and Fairness of the Proposed $14.25 Per Share Cash Buyout Price – UTZ
3 Practical Ways to Build Financial Confidence

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Business Times of Missouri

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.